Statements (54)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
6
|
| gptkbp:bfsParent |
gptkb:EMD_Serono
gptkb:Merck_Serono |
| gptkbp:activities |
stimulates growth
increases protein synthesis promotes lipolysis regulates carbohydrate metabolism |
| gptkbp:approves |
gptkb:legislation
gptkb:United_States requires sterile water must be used within 28 days after reconstitution |
| gptkbp:class |
growth hormone
|
| gptkbp:clinical_trial |
oncology
Phase 3 sports medicine geriatrics pediatric endocrinology adult endocrinology |
| gptkbp:contraindication |
gptkb:Company
active malignancy severe obesity |
| gptkbp:dosage_form |
injection
|
| gptkbp:form |
lyophilized powder
|
| https://www.w3.org/2000/01/rdf-schema#label |
Saizen
|
| gptkbp:indication |
gptkb:Turner_syndrome
chronic kidney disease short stature Prader-Willi syndrome cachexia |
| gptkbp:ingredients |
somatropin
|
| gptkbp:is_used_for |
growth hormone deficiency
|
| gptkbp:manager |
subcutaneous injection
|
| gptkbp:manufacturer |
gptkb:Merck_Serono
|
| gptkbp:marketed_as |
Humatrope
Norditropin Genotropin |
| gptkbp:packaging |
vial
pen injector |
| gptkbp:population |
gptkb:Person
adults |
| gptkbp:regulatory_compliance |
prescription only
|
| gptkbp:shelf_life |
24 months
|
| gptkbp:side_effect |
headache
muscle pain nausea hypertension joint pain injection site reactions carpal tunnel syndrome hypoglycemia edema increased intracranial pressure |
| gptkbp:storage |
refrigerated
|